Wits joins forces with Biovac to bolster SA's vaccine production capabilities
The collaboration will see viral vectored vaccines being produced in South Africa.
Stay updated with breaking news from Patrick Arbuthnot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The collaboration will see viral vectored vaccines being produced in South Africa.
(Getty Images) The University of the Witwatersrand's Antiviral Gene Therapy Research Unit will assist with building specialist skills capacity within Biovac to generate engineered viruses that may be used as Covid-19 and other vaccines. According to Biovac, South Africa desperately needs to build capability to manufacture viral vaccines from scratch rather than importing the active pharmaceutical ingredients. Viral vector-based vaccines are different from most conventional vaccines as they use the body's cells to produce antigens. The University of the Witwatersrand's Anti...